Compare Stocks

→ A new way to collect income from stocks (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CS Credit Suisse Group	$0.89	$0.89	$0.82 ▼ $6.36	$2.77B	1.27	37.84 million shs	N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CS Credit Suisse Group	0.00%	0.00%	0.00%	0.00%	-7.29%

Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CS Credit Suisse Group	2.6877 of 5 stars	3.5	0.0	2.5	0.0	1.3	0.0	1.9

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CS Credit Suisse Group	3.00	Buy	$8.00	798.88% Upside

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CS Credit Suisse Group	$22.88B	0.12	$0.25 per share	3.51	$15.26 per share	0.06

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CS Credit Suisse Group	-$7.64B	$0.65	1.37	∞	N/A	15.12%	23.83%	1.81%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CS Credit Suisse Group	$0.05	5.62%	N/A	7.69%	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CS Credit Suisse Group	2.79	1.53	1.53

Ownership

Institutional Ownership

Company	Institutional Ownership
CS Credit Suisse Group	11.20%

Insider Ownership

Company	Insider Ownership
CS Credit Suisse Group	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CS Credit Suisse Group	50,480	3.11 billion	N/A	Optionable

CS, ESUR, FBH, and HUW Headlines

Source	Headline
	Credit Suisse Pensionskasse adjusts plans following UBS integration ipe.com - April 15 at 4:10 PM
	13 UBS advisors in the Philadelphia D.C. Wealth Management Market named to the Barron's Top 1200 Financial Advisors list tmcnet.com - April 15 at 10:03 AM
	Former Credit Suisse executives can keep bonuses swissinfo.ch - April 14 at 9:09 AM
	Credit Suisse Group (NYSE:CS) Coverage Initiated at StockNews.com americanbankingnews.com - April 14 at 2:16 AM
	FDIC disses Switzerland over approach to Credit Suisse collapse msn.com - April 12 at 12:43 PM
	Swiss gov’t eyes tougher rules for UBS after Credit Suisse rescue msn.com - April 10 at 10:45 PM
	Swiss Eye Tougher Rules For UBS After Credit Suisse Rescue barrons.com - April 10 at 5:44 PM
	Swiss Government Plans to Tighten Banking Rules After Credit Suisse Crisis marketwatch.com - April 10 at 12:44 PM
	Switzerland lays out new 'too big to fail' rules in wake of Credit Suisse banking turmoil last year marketbeat.com - April 10 at 9:09 AM
	Swiss plans to make banks safer after Credit Suisse collapse reuters.com - April 10 at 8:22 AM
	UBS Joint Venture Prepares to Acquire Credit Suisse’s Business in Japan msn.com - April 9 at 9:06 PM
	Report: UBS weighs Credit Suisse China stake swap with Beijing government malaymail.com - April 9 at 4:06 PM
	Singapore court’s verdict was wrong; Credit Suisse unit did ‘incompetent best’ for client: lawyer businesstimes.com.sg - April 9 at 1:11 AM
	Credit Suisse Unit Did ‘Incompetent Best’ for Billionaire Client, Lawyer Says swissinfo.ch - April 8 at 3:06 PM
	Credit Suisse takes fight over $1 billion awarded to billionaire to Singapore’s top court straitstimes.com - April 8 at 10:06 AM
	Credit Suisse Takes Fight Over $743 Million Awarded to Billionaire to Singapore’s Top Court bloomberg.com - April 8 at 12:13 AM
	StockNews.com Begins Coverage on Credit Suisse Group (NYSE:CS) americanbankingnews.com - April 6 at 2:14 AM
	UBS CEO says integrating Credit Suisse will become a ‘case study' for future big bank mergers msn.com - April 5 at 4:11 PM
	Swiss regulator seeks to block investors from accessing Credit Suisse AT1 files swissinfo.ch - April 4 at 7:57 AM
	Swiss regulator seeks to block litigating investors from accessing Credit Suisse AT1 files ft.com - April 4 at 2:57 AM
	UBS Middle East Banker Desh Sharma Leaves to Start Credit Fund bloomberg.com - April 3 at 6:53 AM
	UBS Price Surge After Credit Suisse Deal Rewards Top Tier With Millions finews.com - April 3 at 12:35 AM
	UBS to launch new share buyback as Credit Suisse deal continues to pay off msn.com - April 2 at 8:57 AM
	Swiss bank UBS Group to repurchase up to $2bn in shares in 2024 yahoo.com - April 2 at 3:56 AM

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 3, 2024 6:20 AM
View Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
3 Large-Cap Stocks Buying Back Shares Aggressively
March 18, 2024 6:15 AM
View 3 Large-Cap Stocks Buying Back Shares Aggressively
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
April 3, 2024 9:10 AM
View Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 9, 2024 6:07 AM
View Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?

All Headlines

Company Descriptions

Credit Suisse Group

NYSE:CS

Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse's Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headqua

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial